Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

A Swiss financial centre initiative demands strict climate protection regulations for banks and insurers. UBS, Zurich ...

The number of companies listed on the SIX Swiss Exchange is declining—due not only to structural changes but also partly due ...

The CEO of the investment boutique Baker Steel sees investment opportunities in gold mines, lithium, and rare earths. He ...

Philip Morris shares have risen by more than 50% in the past twelve months – the transformation is going well. In an ...

The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is ...

Following the recent near-financial crash, calls to exclude US government bonds from banks’ capital ratios are growing louder ...

After Accelleron, ABB is preparing its next billion dollar IPO. The new CEO is making his mark and delivers good results.

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Six investment professionals tell our readers how to navigate in view of new US trade barriers. Today Philipp Lienhardt, Head ...

Sensirion does not see itself affected by US tariff policy. New regulation is driving the sensor specialist’s business this ...